炎性乳腺癌（IBC）的流行病学
Epidemiology of inflammatory breast cancer (IBC).
作者信息
Anderson William F, Schairer Catherine, Chen Bingshu E, Hance Kenneth W, Levine Paul H
机构信息
DHHS/NIH/NCI/DCP, Rockville, MD 20852-7244, USA.
出版信息
Breast Dis. 2005;22:9-23. doi: 10.3233/bd-2006-22103.
Abstract
Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer with unknown etiology and generally poor outcome. It is characterized by diffuse edema (peau d'orange) and redness (erythema), although either the disease itself or case definitions have varied over time and place, confounding temporal trends and geographic variations. In this review, we discuss case definitions for IBC and its clinical characteristics; describe its geographic variation, age and racial distribution, incidence and survival patterns, and summarize the very limited information on its epidemiologic risk factors. We also incorporate emerging data from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Program.
摘要
炎性乳腺癌（IBC）是一种罕见且侵袭性强的乳腺癌，病因不明，总体预后较差。其特征为弥漫性水肿（橘皮样变）和发红（红斑），尽管疾病本身或病例定义随时间和地点有所不同，这使得时间趋势和地理差异变得复杂。在本综述中，我们讨论了炎性乳腺癌的病例定义及其临床特征；描述了其地理差异、年龄和种族分布、发病率和生存模式，并总结了关于其流行病学危险因素的非常有限的信息。我们还纳入了美国国立癌症研究所（NCI）监测、流行病学和最终结果（SEER）计划的新数据。
相似文献
1
Epidemiology of inflammatory breast cancer (IBC).炎性乳腺癌（IBC）的流行病学
Breast Dis. 2005;22:9-23. doi: 10.3233/bd-2006-22103.
2
Clinical aspects of inflammatory breast cancer.炎性乳腺癌的临床方面
Breast Dis. 2005;22:35-44. doi: 10.3233/bd-2006-22105.
3
Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy.炎性乳腺癌的分子生物学：在诊断、预后及治疗中的应用
Breast Dis. 2005;22:25-34. doi: 10.3233/bd-2006-22104.
4
A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.2007 - 2009年从医疗记录和监测、流行病学及最终结果数据库中识别炎性乳腺癌病例的标准比较。
Breast J. 2014 Mar-Apr;20(2):185-91. doi: 10.1111/tbj.12234. Epub 2013 Dec 26.
5
Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.1973 年至 2015 年 SEER 数据库中炎性乳腺癌的发病率和生存率。
Breast Cancer Res Treat. 2021 Jan;185(1):229-238. doi: 10.1007/s10549-020-05938-2. Epub 2020 Oct 8.
6
7
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.炎性乳腺癌发病率及生存率趋势：美国国立癌症研究所的监测、流行病学与最终结果计划
J Natl Cancer Inst. 2005 Jul 6;97(13):966-75. doi: 10.1093/jnci/dji172.
8
Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients.炎性乳腺癌的分子流行病学特征：埃及与美国患者的比较
Breast Cancer Res Treat. 2008 Nov;112(1):141-7. doi: 10.1007/s10549-007-9833-z. Epub 2007 Dec 4.
9
Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program.炎性乳腺癌：监测、流行病学及最终结果（SEER）项目的经验
J Natl Cancer Inst. 1985 Feb;74(2):291-7.
10
Population-based statistics for women diagnosed with inflammatory breast cancer (United States).美国炎性乳腺癌女性患者的基于人群的统计数据。
Cancer Causes Control. 2004 Apr;15(3):321-8. doi: 10.1023/B:CACO.0000024222.61114.18.
引用本文的文献
1
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study.用于HER2阳性炎性乳腺癌的含或不含蒽环类药物的新辅助HER2靶向治疗方案：一项多中心回顾性研究
Breast Cancer Res Treat. 2025 Nov;214(1):69-77. doi: 10.1007/s10549-025-07795-3. Epub 2025 Aug 2.
2
Clinicogenomic characterization of inflammatory breast cancer.炎性乳腺癌的临床基因组特征
Clin Cancer Res. 2025 May 16. doi: 10.1158/1078-0432.CCR-24-2081.
3
Bilateral breast swelling in a pregnant woman with high-grade B-cell lymphoma, potentially Burkitt lymphoma.一名患有高级别B细胞淋巴瘤（可能为伯基特淋巴瘤）的孕妇出现双侧乳房肿胀。
Radiol Case Rep. 2024 Dec 21;20(3):1475-1481. doi: 10.1016/j.radcr.2024.11.050. eCollection 2025 Mar.
4
Characterization of mammographic markers of inflammatory breast cancer (IBC).炎性乳腺癌（IBC）的乳腺钼靶标记物特征
Phys Med. 2025 Jan;129:104870. doi: 10.1016/j.ejmp.2024.104870. Epub 2024 Dec 9.
5
Immediate Breast Reconstruction for Inflammatory Breast Carcinoma: A Scoping Review.炎性乳腺癌的即刻乳房重建：一项范围综述
J Surg Oncol. 2025 Apr;131(5):775-781. doi: 10.1002/jso.27959. Epub 2024 Oct 17.
6
Clinicogenomic characterization of inflammatory breast cancer.炎性乳腺癌的临床基因组特征
bioRxiv. 2024 May 10:2024.05.07.592972. doi: 10.1101/2024.05.07.592972.
7
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.TBCRC 039：术前 ruxolitinib 联合或不联合紫杉醇治疗三阴性炎性乳腺癌的 II 期研究。
Breast Cancer Res. 2024 Jan 31;26(1):20. doi: 10.1186/s13058-024-01774-0.
8
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy.新辅助全身治疗炎性乳腺癌的治疗反应、肿瘤浸润淋巴细胞与临床结局
Cancer Res Commun. 2024 Jan 24;4(1):186-199. doi: 10.1158/2767-9764.CRC-23-0285.
9
Systematic Review and Meta-Analysis of Treatment Effects on Survival in Patients with Inflammatory Breast Cancer.系统评价和荟萃分析炎性乳腺癌患者生存治疗效果。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3335-3343. doi: 10.31557/APJCP.2023.24.10.3335.
10
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.初发性转移性HER2阳性炎性乳腺癌的临床结局
NPJ Breast Cancer. 2023 Jun 2;9(1):50. doi: 10.1038/s41523-023-00555-w.
本文引用的文献
1
Acute Mammary Carcinoma: (Volkmann's Mastitis Carcinimatosa).急性乳腺癌：（福尔克曼氏癌性乳腺炎）
Can Med Assoc J. 1916 Jun;6(6):499-515.
2
Bilateral Thoracic Zosteroid Spreading Marginate Telangiectasia-probably a Variety of "Carcinoma Erysipelatodes" (C. Rasch)-associated with Unilateral Mammary Carcinoma, and better termed "Carcinoma Telangiectaticum".双侧胸部带状疱疹样播散性边缘性毛细血管扩张——可能是“丹毒样癌”（C. 拉施）的一种类型——与单侧乳腺癌相关，更宜称为“毛细血管扩张性癌”。
Proc R Soc Med. 1933 Oct;26(12):1549-51. doi: 10.1177/003591573302601236.
3
Inflammatory carcinoma of the breast.炎性乳腺癌
Surg Gynecol Obstet. 1948 Oct;87(4):417-24.
4
Carcinoma of the breast; results from statistical research.乳腺癌；统计研究结果
Br J Radiol. 1948 Dec;21(252):583-90. doi: 10.1259/0007-1285-21-252-583.
5
V. A Study of Carcinoma Mastitoides.五、乳腺样癌的研究
Ann Surg. 1911 Jul;54(1):69-77. doi: 10.1097/00000658-191107000-00006.
6
Inflammatory local recurrence after breast-conservation therapy for noninflammatory breast cancer.非炎性乳腺癌保乳治疗后的炎性局部复发
Am J Clin Oncol. 2005 Aug;28(4):431-2. doi: 10.1097/01.coc.0000145288.23823.9d.
7
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.炎性乳腺癌发病率及生存率趋势：美国国立癌症研究所的监测、流行病学与最终结果计划
J Natl Cancer Inst. 2005 Jul 6;97(13):966-75. doi: 10.1093/jnci/dji172.
8
Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy.接受多模态治疗的局部晚期和炎性乳腺癌患者的长期随访
J Clin Oncol. 2004 Oct 15;22(20):4067-74. doi: 10.1200/JCO.2004.04.068.
9
Possible relationship between menopause and age at onset of breast cancer.更年期与乳腺癌发病年龄之间的潜在关系。
Cancer. 1950 May;3(3):410-4. doi: 10.1002/1097-0142(1950)3:3<410::aid-cncr2820030303>3.0.co;2-h.
10
Increasing evidence for a human breast carcinoma virus with geographic differences.越来越多的证据表明存在一种具有地域差异的人类乳腺癌病毒。
Cancer. 2004 Aug 15;101(4):721-6. doi: 10.1002/cncr.20436.
Zotero 插件